Tag: Eli Lilly

Eli Lilly investors endured another bruising week as the pharmaceutical giant's stock slid nearly 5% on Friday, closing at €750. ...

Eli Lilly & Co. is executing a multi-billion dollar expansion on two critical fronts, yet its stock performance tells a ...

Pharmaceutical giant Eli Lilly is strategically expanding its empire beyond its blockbuster weight-loss drugs. In a series of moves totaling ...

Eli Lilly & Company's stock posted significant gains, outperforming the broader pharmaceutical sector, following two major announcements. The company secured ...

Eli Lilly and Company is approaching a pivotal period marked by two significant catalysts. While the pharmaceutical giant's stock has ...

While Eli Lilly continues to post impressive prescription figures for its blockbuster weight-loss medications, a growing sense of unease is ...

Pharmaceutical giant Eli Lilly is approaching a pivotal regulatory milestone. The U.S. Food and Drug Administration (FDA) is expected to ...

The pharmaceutical landscape for weight-loss medications is transforming into a fiercely competitive battleground. Recent clinical advancements from Danish rival Novo ...

In a move that sent shockwaves through the market, global banking giant HSBC has downgraded its stance on Eli Lilly ...

To address overwhelming global demand for its blockbuster diabetes and weight-loss treatments, Eli Lilly and Company is embarking on another ...